Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING‐Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy is a research paper published in Arthritis & Rheumatology (2025). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 75N91019D000024
NCI NIH HHS
Grant: 75N91019D00024
Intramural NIH HHS
Grant: Z99 AI999999
Intramural Research Program at the National Institute of Allergy Immunology and Infectious Diseases of the National Institutes of Health
Fields of Study
MeSH Terms